94
Views
0
CrossRef citations to date
0
Altmetric
Original Article

From Adaptation to Maladaptation – An Introduction to the Spectrum of Circulatory Responses in Health and Disease

Pages 311-312 | Published online: 08 Jul 2009

References

  • Opie L H. Control of the circulation. The Heart, Physiology and Metabolism, L H Opie. Raven Press, New York 1991; 52–66
  • Gahmberg C G, Nortamo R, Li R, Valmu L. Leukocyte cell adhesion proteins: from molecular dissection to clinical applications. Ann Med 1992; 24: 329–35
  • Lefer A M, Lefer D J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc Res 1996; 32: 743–51
  • MacDougall J D. Blood pressure responses to resistive, static and dynamic exercise. Cardiovascular Response to Exercise, F G Fletcher. Futura Publishing Company Inc, Mount Kisco, NY 1994; 155–73
  • Lakatta E G. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 1993; 87: 631–6
  • Burke G L, Manolio T A. Epidemiology of established major cardiovascular risk factors. Prognosis and Risk Assessment in Cardiovascular Disease, A S Kapoor, B N Singh. Churchill Livingstone, New York 1993; 61–72
  • Reaven G M, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374–81
  • Forsstrdm J J, Dalton K J. Artificial neural networks for decision support in clinical medicine. Ann Med 1995; 27: 509–17
  • Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 1996; 11: 245–51
  • Holubarsch C, Hasenfuss G, Thierfelder L, Pieske B, Just H. The heart in heart failure. Ventricular and myocardial alterations. Eur Heart J 1992; 12(Suppl C)8–13
  • Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248–54
  • Swedberg K, Sharpe N. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction. Eur Heart J 1996; 17: 1306–11
  • Cleland J G, Dutka D P. Optimising heart failure pharmacotherapy: the ideal combination. Br Heart J 1994; 72(Suppl)S73–9
  • Cohn J N, Bristow M R, Chien K R, et al. Report of the National Heart, Lung, and Blood Institute special emphasis panel on heart failure research. Circulation 1997; 95: 766–70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.